Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental Validation
Open Access
- 1 September 2006
- journal article
- Published by Elsevier BV
- Vol. 281 (37), 27613-27620
- https://doi.org/10.1074/jbc.m601389200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The clinical potential of chemokine receptor antagonistsPharmacology & Therapeutics, 2005
- Structure-based Drug Discovery Using GPCR Homology Modeling: Successful Virtual Screening for Antagonists of the Alpha1A Adrenergic ReceptorJournal of Medicinal Chemistry, 2005
- Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor AntagonistPublished by Elsevier BV ,2005
- PREDICT modeling and in-silico screening for G-protein coupled receptorsProteins-Structure Function and Bioinformatics, 2004
- High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library ScreeningJournal of Chemical Information and Computer Sciences, 2004
- HierVLS Hierarchical Docking Protocol for Virtual Ligand Screening of Large-Molecule DatabasesJournal of Medicinal Chemistry, 2003
- The CC Chemokine Eotaxin (CCL11) Is a Partial Agonist of CC Chemokine Receptor 2bPublished by Elsevier BV ,2001
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier BV ,2000
- The N-terminal Extracellular Segments of the Chemokine Receptors CCR1 and CCR3 Are Determinants for MIP-1α and Eotaxin Binding, Respectively, but a Second Domain Is Essential for Efficient Receptor ActivationJournal of Biological Chemistry, 1998
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990